Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Operating Margin: 2020-2025

Historic Operating Margin for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -89.84%.

  • Biofrontera's Operating Margin fell 3480.00% to -89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.40%, marking a year-over-year increase of 736.00%. This contributed to the annual value of -46.11% for FY2024, which is 2044.00% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Operating Margin is -89.84%, which was down 59.73% from -56.25% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Operating Margin ranged from a high of -13.63% in Q4 2024 and a low of -371.60% during Q3 2021.
  • In the last 3 years, Biofrontera's Operating Margin had a median value of -56.25% in 2025 and averaged -63.78%.
  • Per our database at Business Quant, Biofrontera's Operating Margin slumped by 29,952bps in 2021 and then soared by 28,740bps in 2022.
  • Biofrontera's Operating Margin (Quarterly) stood at -20.51% in 2021, then tumbled by 3,451bps to -55.02% in 2022, then skyrocketed by 1,854bps to -36.48% in 2023, then surged by 2,284bps to -13.63% in 2024, then crashed by 3,480bps to -89.84% in 2025.
  • Its last three reported values are -89.84% in Q3 2025, -56.25% for Q2 2025, and -52.95% during Q1 2025.